Antifungal Flashcards
Amphotercin B
Oral absorption
Poor oral absorption
Use only if fungi with the lumen of GI tract
Itraconazole oral absorption
Best with food
Flucornazole oral absorption
Nearly complete
Voriconazole oral absorption
90%
Flucytosine oral absorption
Absorb rapidly and well in git
Caspofungin oral absorption
ONLY IV
Antifungal good CSF
Fluconazole
Voriconazole
Flucytosine
Amphotercin B protein binding
90%
Itraconazole BP
99%
Caspofungin BP
Highly
Flucytosine BP
Minimal
Antifungal Liver metabolism
Itraconazole
Voriconazole
Antifungal minimal metabolism
Flucytosine
Caspofungin
Eliminated in the urine antifungal
Amphotercin B
Fluconazole
Flucytosine
Caspofungin
Eliminated in GIT antifungal
Caspofungin
Eliminated in the liver antifungal
Itraconazole
Voriconazole
Amphotercin B half life
15days
Itraconazole t1/2
24-42hr
Fluconazole half life
25-30hr
Voriconazole half life
6hr
Caspofungin half life
25-30hr
Flucytosine half life
3-6h Normal
Renal failure
As long as 200h
Amphotercin B
Polyene
Nystatin
Polymenes
Clotrimazole
Imidazole
Miconazole
Imidazole
Ketoconazole
Imidazole
Itraconazole
Triazole
Fluconazole
Triazole
Voriconazole
Triazole
5-flucytosine
Pyrimidine analogue
Caspofungin
Echinocandins
Terbinafine
Topical preparation
Polyenes MOA
Strong affinity for ergosterol
Binding to it causes disruption to fungal cell membrane
Amphotercin B ROA
Oral
IV
Intraarticular
Nystatin ROA
Topical (creams ointment suppositories)
Amphotercin B SE
Infusion rxn (shake and bake syndrome; fever and chills )
Thrombophlebitis
Nephrotoxic
Bone marrow suppression
Nystatin SE
It is not absorbed to a significant degree from skin, mucous membranes, or the gastrointestinal tract. As a result, nystatin has little toxicity.
Amphotercin B DDI
- aminoglycosides,
2. vancomycin,
3. NSAIDs,
4. cyclosporine
All will increase nephrotoxic potential.
Azoles MOA
Inhibit ergosterol synthesis, by inhibiting α- demethylase, which demethylates lanosterol to ergosterol
Clotrimazole ROA
Topical
Cream lotion powder pessary
Miconazole ROA
Cream powder
Oral gel 2%
Ketoconazole ROA
Topical
Shampoo
Itraconazole ROA
Oral only
best absorb with food
Fluconazole ROA
Oral
IV
Voriconazole ROA
Oral (>90% absorb)
IV
Amphotercin B clinical application
Invasive aspergillosis
Histoplasmosis
Systemic candidiasis
Nystatin clinical application
Vaginal candidiasis
Imidazole are
Useful alternative to ____________
Amphotercin B for treating different systemic fungal infection
Clotrimazole clinical application
Clotrimazole - skin and vulvovaginal infections caused by a wide variety of fungi, including Candida.
Miconazole clinical application
Miconazole - tineal infections and vulvovaginal candidiasis; oral gel for thrush (alternative to nystatin)
Most potent triazole
Itraconazole
Itraconazole clinical application
Itraconazole - Trichophyton infections, Histoplasmosis,
Fluconazole clinical application
Fluconazole - Cryptococcosis, candidiasis in AIDS patients, vaginal candidiasis
Voriconazole clinical application
Voriconazole - Candidaemia; invasive aspergillosis (alternative to amphotericin B)
Itraconazole SE
GIT disturbance
Mild rash
May have SJS
- Headache Serious side effects:
- cardiac suppression (due to negative inotropic action on cardiac muscle)
- hepatotoxicity
Fluconazole SE
GIT disturbance
Mild rash
May have SJS
Voriconazole se
GIT disturbance
Mild rash
May have SJS
- hepatitis,
- visual disturbances: -colour perception defect,
-reduced visual acuity,
-photophobia.
Itraconazole
Fluconazole
DDI
Warfarin
Sulphonylurea
Digoxin
(Both anole inhibit hepatic CYP450 enzyme)
PPI
Antacid
H2RA
(Reduce anole absorption)
Voriconazole DDI
Carbamazepine
Erythromycin
Voriconazole is both a substrate and inhibitor of CYP450 enzymes.
Avoid concomitant use of
potent CYP450 inducers, like carbamazepine, and
inhibitors, like erythromycin.
Flucytosine MOA
Disrupt synthesis of fungal RNA and DNA
Caspofungin MOA
Inhibit the synthesis of β(1–3)- glucan =>disruption of the fungal cell wall and cell death.
Terbinafine MOA
Squalene accumulates in the cell and Inhibits squalene epoxidase which is
involved in the synthesis of ergosterol from squalene.
Flucytosine ROA
Oral
Caspofungin ROA
IV
Terbinafine ROA
Topical - 1% cream: for treatment of dermatophytic infections.
Oral – not commonly prescribed.
Flucytosine clinical application
Effective against systemic yeast infections if given orally.
Systemic Candidiasis and Cryptococcal meningitis (combined with amphotericin B).
Combination allows use of amphotericin B at a lower dose, thus reducing the risk of nephrotoxicity.
Combine with itraconazole for chromoblastomycosis
Caspofungin Clinical application
Mucocutaneous candidiasis and candidaemia, usually in immuno-compromised patients
Salvage therapy in patients with invasive aspergillosis (failed response to amphotericin B)
Terbinafine clinical application
Against dermatophytic infection of the skin and nails (“keratophilic”).
Flucytosine SE
- Bone marrow suppression is most serious. Monitor leucocytes and platelets weekly.
- Hepatotoxicity - mild and reversible damage is common; monitor liver enzymes (ALT and AST weekly.
Caspofungin SE
- GIT-related symptoms, fever, histamine-like facial flushing rash, pruritus
- thrombophlebitis
- Foetal toxicity (Category C) - Avoid use in pregnancy.
Terbinafine SE
Erythema, dry skin.
(These can be avoided by not using > 4 weeks).
Flucytosine DDI
Quinidine
Causes dysthymia
Caspofungin DDI
- rifampicin
- Carbamazepine
- cyclosporine
(1), (2) are CYP 450 inducers; reduce caspofungin plasma levels
Risk of hepatotoxicity